Batu Biologics Announces the Release of the Starve The Tumor Immunotherapy Blog

Batu Biologics Announces the Release of the Starve The Tumor Immunotherapy Blog

Clinical Stage Immuno-Oncology Company Releases Media Platform to Provide Background Information on Lead Technology

Today, Batu Biologics announced the release of the Starve The Tumor Video Blog, a series of informational videos and articles designed to provide background information on our lead therapeutic ValloVax. Batu Biologics’ lead clinical candidate, ValloVax, is a first-in-class placenta derived endothelial cell based vaccine designed to stimulate an immune response against several tumor angiogenesis associated antigens for the treatment of solid tumor carcinomas.

Read the full article at businesswire.com

Leave a Reply

Your email address will not be published. Required fields are marked *